BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 37328622)

  • 1. [
    Zhu Z; Cheng K; Yun Z; Zhang X; Hu X; Liu J; Wang F; Fu Z; Yue J
    Eur J Nucl Med Mol Imaging; 2023 Sep; 50(11):3425-3438. PubMed ID: 37328622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of preoperative [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Huo L; Li X
    Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1780-1791. PubMed ID: 36695823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of
    Yokose T; Kitago M; Matsusaka Y; Masugi Y; Shinoda M; Yagi H; Abe Y; Oshima G; Hori S; Endo Y; Toyama K; Iwabuchi Y; Takemura R; Ishii R; Nakahara T; Okuda S; Jinzaki M; Kitagawa Y
    Cancer Med; 2020 Jun; 9(12):4059-4068. PubMed ID: 32281301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of [
    Qiao K; Qin X; Fu S; Ren J; Jia J; Hu X; Tao Y; Yuan S; Wei Y
    Eur Radiol; 2024 Mar; 34(3):1948-1959. PubMed ID: 37670186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the clinical value of baseline [
    Ding J; Qiu J; Hao Z; Huang H; Liu Q; Liu W; Ren C; Hacker M; Zhang T; Wu W; Li X; Huo L
    Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4036-4050. PubMed ID: 37493664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical FAP Expression Reflects
    Spektor AM; Gutjahr E; Lang M; Glatting FM; Hackert T; Pausch T; Tjaden C; Schreckenberger M; Haberkorn U; Röhrich M
    J Nucl Med; 2024 Jan; 65(1):52-58. PubMed ID: 38167622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    Wei Y; Cheng K; Fu Z; Zheng J; Mu Z; Zhao C; Liu X; Wang S; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1671-1681. PubMed ID: 34870727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of Al
    Lyu Z; Han W; Zhang Q; Zhao H; Liu S; Wang Y; He J; Zhao C; Tian L; Fu P
    Cancer Imaging; 2023 Sep; 23(1):86. PubMed ID: 37700343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of tumour grade and survival outcome using pre-treatment PET- and MRI-derived imaging features in patients with resectable pancreatic ductal adenocarcinoma.
    Dunet V; Halkic N; Sempoux C; Demartines N; Montemurro M; Prior JO; Schmidt S
    Eur Radiol; 2021 Feb; 31(2):992-1001. PubMed ID: 32851447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation and pilot clinical study of [
    Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [
    Guberina N; Kessler L; Pöttgen C; Guberina M; Metzenmacher M; Herrmann K; Mucha M; Rischpler C; Indenkämpen F; Siveke JT; Treckmann J; Umutlu L; Kasper S; Fendler WP; Stuschke M
    Sci Rep; 2022 Sep; 12(1):16261. PubMed ID: 36171444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of
    Röhrich M; Naumann P; Giesel FL; Choyke PL; Staudinger F; Wefers A; Liew DP; Kratochwil C; Rathke H; Liermann J; Herfarth K; Jäger D; Debus J; Haberkorn U; Lang M; Koerber SA
    J Nucl Med; 2021 Jun; 62(6):779-786. PubMed ID: 33097632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [
    Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Li X; Lu N; Lin L; Chen Y; Yang S; Wang H; Liu X; Wu C; Xue X; Su X; Bai X; Liang T
    J Nucl Med; 2024 Feb; 65(2):206-212. PubMed ID: 38176719
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Zhao Y; Ren J
    Front Immunol; 2023; 14():1266843. PubMed ID: 38035081
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
    J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gallium-68-labeled fibroblast activation protein inhibitor-46 PET in patients with resectable or borderline resectable pancreatic ductal adenocarcinoma: A phase 2, multicenter, single arm, open label non-randomized study protocol.
    Karbhari A; Mosessian S; Trivedi KH; Valla F; Jacobson M; Truty MJ; Patnam NG; Simeone DM; Zan E; Brennan T; Chen H; Kuo PH; Herrmann K; Goenka AH
    PLoS One; 2023; 18(11):e0294564. PubMed ID: 38011131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical value of [
    Rao W; Fang XH; Zhao Y; Wang Y; Zhang B; Wei Z; Kong X; Cai JZ; Yang G; Xie M
    Jpn J Radiol; 2024 May; 42(5):536-545. PubMed ID: 38316724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [
    Sun F; Wang C; Feng H; Yu F; Zhang X; Zhang P; Du X
    Mol Pharm; 2023 May; 20(5):2634-2641. PubMed ID: 37043243
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Mi L; Zhao Y; Zhao X; Yin F; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J
    Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.